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One-year evaluation of a new 
restorative glass ionomer cement for 
the restoration of non-carious cervical 
lesions in patients with systemic 
diseases: a randomized, clinical trial
Objective: This randomized and clinical trial aimed to evaluate the 
performance of a new restorative Glass Ionomer Cement (GIC) for the 
restoration of non-carious cervical lesions (NCCLs) of patients with systemic 
diseases compared with a posterior resin composite after 12 months. 
Methodology: 134 restorations were placed at 30 patients presenting 
systemic diseases by a single clinician. NCCLs were allocated to two groups 
according to restorative system used: a conventional restorative GIC [Fuji 
Bulk (GC, Tokyo Japan) (FB)] and a posterior resin composite [G-ænial 
Posterior (GC, Tokyo Japan) (GP)] used with a universal adhesive using 
etch&rinse mode. All restorative procedures were conducted according to 
manufacturer’s instructions. Restorations were scored regarding retention, 
marginal discoloration, marginal adaptation, secondary caries, surface 
texture, and post-operative sensitivity using modified United States Public 
Health Service (USPHS) criteria after 1 week (baseline), 6, and 12 months. 
Descriptive statistics were performed using chi-square tests. Cochran Q and 
Mc Nemar’s tests were used to detect differences over time. Results: After 12 
months, recall rate was 93% and the rates of cumulative retention failure for 
FB and GP were 4.9% and 1.6% respectively. Both groups presented similar 
alpha rates for marginal adaptation (FB 86.2%, GP 95.5%) and marginal 
discoloration (FB 93.8%, GP 97%) at 6-month recall, but FB restorations 
showed higher bravo scores than GP restorations for marginal adaptation and 
marginal discoloration after 12 months (p<0.05). Regarding surface texture, 2 
FB restorations (3.1%) were scored as bravo after 6 months. All restorations 
were scored as alpha for secondary caries and postoperative sensitivity 
after 12 months. Conclusion: Although the posterior resin composite 
demonstrated clinically higher alpha scores than the conventional GIC for 
marginal adaptation and discoloration, both materials successfully restored 
NCCLs at patients with systematic disease after a year. Clinical relevance: 
Due to its acceptable clinical results, the tested conventional restorative GIC 
can be used for the restoration of NCCLs of patients with systemic diseases.
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Introduction
Non-carious cervical lesions (NCCLs) develop in 
exposed root surfaces due to several factors, including 
abrasion, friction, and stress forces,1 and they are 
presented in different clinical forms, such as shallow 
grooves, large wedge-shaped defects with sharp line 
angles, and disc-shaped lesions. They are mostly 
observed on incisors, canines, and premolars, and 
they have been shown to affect the maxillary teeth 
more than the mandibular teeth.2 
Abrasion of the root is associated with esthetic 
problems, hypersensitivity, and bacterial plaque 
accumulation, which are considered the main reasons 
for treatment and restoration.3 Multiple factors are 
involved in the occurrence of NCCLs, and the lesions 
depth and width can vary.4 Although their etiology 
differs among cases, the prevalence of NCCLs is 
increasing with the aging of the population, and 
thus the risk of developing systemic disease is also 
increasing.5-7
Either glass ionomer cement (GIC) or resin 
composite in combination with resin-based adhesive 
are preferred to restore NCCLs. The choice is usually 
based on the clinician’s preference and ease of handling 
the material without considering the durability of 
restorations supported by strong clinical evidence. 
A number of clinical trials have assessed the 
performance of GICs for restoring NCCLs, and these 
trials have demonstrated acceptable clinical results.8-11 
Fluoride release from GICs may provide effective 
tooth surface protection against demineralization, 
also supporting teeth integrity.12 The weaker physical 
properties of GICs are considered as disadvantages 
compared to resin composites, along with their poor 
esthetic properties (e.g., limited range of shades).1,12 
GICs bond to teeth by micromechanical and chemical 
bonding, and therefore they are considered self-
adhesive materials.13 
Recently, a new conventional GIC system (Fuji 
Bulk; GC, Tokyo Japan) was introduced.14 This new 
GIC offers a faster setting time, so that it can be 
used for older patients and patients who are unable 
to stay in the dental chair for a long time.14 The 
manufacturer claims that a purpose-designed glass 
filler and a new higher-molecular-weight polyacrylic 
acid enable this GIC to have increased resistance.14 
Hence, this material may be a better choice for use 
in geriatric patients and individuals with dry mouth 
or active caries, and also for patients with systemic 
diseases who have to struggle with more challenging 
oral conditions than healthy individuals.
Increases in life expectancy have been followed 
by changes in the morbidities rates that mostly affect 
older individuals. Chronic and systemic diseases, such 
as heart disease,15 cancer,16 and diabetes mellitus,17 
are most likely to affect older individuals, and these 
diseases and the medicine used to treat them can 
affect the flow of saliva and dental health. Oral 
environment in such patients may not benefit from 
the normal buffering capacity of saliva. Therefore, 
restorative materials for these patients should be 
chosen carefully, and treatments may require more 
attention due to their sensitive condition. A bioactive, 
biocompatible, and fast-setting fluoride-releasing GIC 
restorative material with good resistance to wear and 
acidic conditions may be suitable for such patients, 
particularly for restoring lesions where the restorative 
material are in contact with vulnerable gingival tissues. 
Note that the limited data reported to date regarding 
the performance of GICs on NCCLs have been obtained 
from studies carried out on healthy individuals with 
no systemic disease or gingival problems.18 This is 
the major limitation to investigate clinical scenarios 
for most cases where NCCLs, systemic disease, and 
periodontal problems may occur with them. Therefore, 
this study evaluated the clinical performance of a 
new conventional GIC compared to a resin composite 
applied with a universal adhesive for the restoration 
of NCCLs in patients with systemic diseases. The null 
hypothesis was that there would be no differences in 
clinical performance between conventional GIC and 
resin composite restoration.
Methodology
This was a randomized and controlled clinical trial. 
The study protocol was approved by the Institutional 
Research Ethics Committee for Clinical Investigations 
(KA-19010) and registered at ClinicalTrials.gov 
(NCT04266210). Patients provided written informed 
consent prior to the beginning of any treatment. 
The experimental design followed the Consolidated 
Standards of Reporting Trials (CONSORT) statement.19
Sample size calculation
The sample size was calculated using G*Power 
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software (version 3.1) with 95% confidence interval, 
90% power, and 0.40 effect size in the chi-square test. 
The highest degree of freedom was assumed to be 5 
and the minimum restoration number was determined 
to be 51 per group. Considering the possibility of 
dropouts during the study period, the sample size 
was increased to 67 in each group and a total of 134 
restorations were performed.
Patient screening
A clinician recruited participants who met the 
inclusion criteria (Figure 1) among patients seeking 
routine dental care from the Restorative Dentistry 
Department. Non-retentive lesions with a cavosurface 
margin involving at most 50% of the enamel were 
included. Assessments were carried out using an 
explorer, a mouth mirror, and a periodontal probe. The 
cold test was also performed for sensitivity to avoid 
the inclusion of patients with severe hypersensitivity. 
Patients were asked to grade their pain on a scale 
ranging between 0 and 10 and some patients were 
excluded if the pain rating was 7 or higher. 
Patients older than 50 years who had at least one 
systemic disease (Table 1) were included in the study. 
All patients had at least 20 teeth20,21 in occlusion and 
at least 2 teeth with NCCLs that had to be restored. 
Teeth had to be vital without mobility. Patients with 
severe caries or heavy bruxism were excluded. A 
total of 72 patients were screened for the study and 
30 participants were selected. A total of 134 NCCLs 
were restored in 30 (17 female, 13 male) patients 
with a mean age of 61.8 years. The study design is 
presented in Figure 1.
Randomization
Randomization was carried out by another clinician 
who was not involved in the research protocol. The 
teeth were randomized for each of the two restorative 
treatments by a random number table generated by 
the program “Research Randomized Program” (http://
www.randomizer.org/form.htm). Similar numbers of 
restorations were placed in both groups, and each 
patient received at least two restorations. In some 
cases, more lesions were restored following the same 
randomization protocol.
Restorative treatments
The materials used in the study are listed in Figure 
2. Patients with lesions 1~3 mm deep, were included in 
the study. Before starting the restorative procedures, 
the distribution of demographic characteristics of 
Figure 1- Flow diagram of the study. FB: Fuji Bulk, GP: G- ænial Posterior, nP: number of patients, nR: number of restorations
Systemic disease Number of patients
Hypertension 16
Cancer patients in remision 6
Diabetus Mellitus 5
Hemophilia 1
Heart disease – coronery artery disease 4
Rheumatoid arthritis 2
Chronic obstructive pulmonary disease 2
Lupus eritematozus 1
Table 1- Systemic diseases of patients included in the study
OZ FD, MERAL E, ERGİN E, GURGAN S 
J Appl Oral Sci. 2020;28:e202003114/10
patients according to sex and age were recorded 
(Table 2). Data on NCCLs according to tooth type, arch, 
degree of angle, cervicoincisal height, buccolingual 
depth, and restorative systems are presented in 
Table 3.
Patients received dental prophylaxis and oral 
hygiene instructions one week before treatments. 
The gingival index (GI) and plaque index (PI) of each 
tooth were determined before treatment.22 In total, 
13 (9.7%) teeth were scored as 0 (no bleeding), 69 
teeth (51.5%) were scored as one (some bleeding 
after probing), 45 (33.6%) teeth were scored as 
two (bleeding immediately after probing), and seven 
(5.2%) teeth were scored as three (bleeding on 
probing spreading toward the marginal gingiva). The 
overall PI for patients was 0.96 (SD: 0.32, n=134). 
Patients’ salivary flow rate and saliva pH were checked 
before starting treatments. Mean unstimulated and 
stimulated salivary flow rates were 0.19±0.75 and 
0.82±1.23 mL/min, respectively, both flows were 
low. Six patients had salivary pH 6.8–7.8 (healthy 
saliva) and 24 patients had moderately acidic saliva 
(pH 6.0–6.6). 
Material /Manufacturer Content Application











Shake the capsule or tap its side on a hard surface to loosen 
the powder. To activate the capsule, push the plunger until it is 
fully depressed with the main body and hold it down for 2 sec) 
Ensure the plunger is fully pressed to avoid the incorrect mixing 
ratio of powder and liquid. Immediately set it into a mixer (or an 
amalgamator) and mix for 10 sec (+/- 4,000 RPM). Immediately 
remove the mixed capsule from the mixer and load it into the 
GC CAPSULE APPLIER. Make two clicks to prime the capsule 
then syringe. The working time is 1 minute 15 sec from start of 
mixing at 23°C. Within 10 sec maximum after mixing, start to 
extrude the mixture directly into the preparation.  
 G-ænial Posterior / GC 
Corporation, Tokyo, 
Japan
Pre-polymerized fillers : Silica containing, 





Place in cavity with 2 mm increments. Light-cure with 1200 mW/
cm2 LED for 20 sec.










Apply phosphoric acid etching gel (37%)  to enamel and dentin 
for 15 sec, leave it in place then rinse rinse and dry
Apply bond to the entire lesion with the applicator brush 
Leave undisturbed for 10 sec after the end of application.
Dry thoroughly for 5 sec with air under maximum air pressure
Light-cure bond with 1200 mW/cm2 LED for 10sec.
MDP: 10-Methacryloyloxydecyl dihydrogen phosphate, BHT: Butylated hydroxytoluen, MDTP: Methacryloyloxydecyl dihydrogen 
thiophosphate.








Table 2- Demographic Characteristics of Patients


















Table 3- Characteristics and Distribution of NCCLs
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The lesions were cleaned with a slurry of pumice 
and water on slow-rotating rubber cup in a slow-speed 
hand piece, rinsed, and dried. One operator performed 
all restorations; despite having more than 8 years of 
experience, the operator performed 10 restorations 
with each test material in patients not included in 
the study before starting the trial. Each restoration 
was scored as alpha by the two previously calibrated 
operator. At this point, the operator was considered 
calibrated to perform restorative procedures during the 
study.23 Restorative procedures were carried out after 
isolating the lesions using cotton rolls. Restorative 
materials (Fuji Bulk [FB, n=67] and G-ænial Posterior 
[GP, n=67]) were applied according to the respective 
manufacturer’s instructions listed in Figure 2. Resin 
composite restorations were light-cured using an LED 
light-curing unit (Radii Plus; SDI, Victoria, Australia) 
set at 1200 mW/cm2. The intensity was checked 
regularly using a radiometer (Benlioğlu radiometer; 
Benlioğlu Dental, Ankara, Turkey) before each use. 
All restorations were contoured using flame-shaped 
fine finishing diamond burs  (Diatech, Charleston, 
SC, USA) in a high-speed hand piece under water 
spray, and then polished with Optidisc discs (Kerr 
Corporation, Orange, CA, USA). Coating material 
(EQUIA Forte Coat, GC, Tokyo, Japan) was applied 
with a microbrush to the surfaces of FB restorations 
and light-cured for 20 s.
Blinding and calibration for clinical evaluation
Before starting the evaluations, two experienced 
examiners other than the operator were trained for 
both intra-examiner and inter-examiner reliability. 
For this purpose, they observed 10 photographs 
representing the scores for each criterion. The 
percentage of agreement between examiners was 
at least 85%. The examiners who were not involved 
with the procedures of restoration and blinded to the 
group assignment performed the clinical evaluations 
independently using mirrors, probes, and air streams. 
Disagreements were resolved by consensus during 
evaluations. Patients were also unaware and blinded 
to the treatments (i.e., which teeth received which 
type of restoration).
Restorations were evaluated at baseline (1 week 
after restoration placement) and 6 and 12 months after 
placement for retention, marginal adaptation, marginal 
discoloration, surface texture, and postoperative 
sensitivity according to modified United States Public 
Health Service (USPHS) criteria.24 New and empty 
evaluation forms were filled by the examiners to 
remain blinded to group assignments at recall. 
Restoration retention rates were calculated using 
an equation (Cumulative failure % = [(PF+NF)/
(PF+RR)] x 100%, PF = number of previous failures 
before the current recall; NF=number of new failures 
during the current recall; RR=number of restorations 
recalled for the current recall).21,25
Statistical analyses 
Cohen’s kappa statistic was used to test inter-
examiner agreement. Comparisons of the groups in 
each category were performed using Pearson’s chi-
square test. The baseline scores were compared to 
those at recall visits using Cochran’s Q-test followed 
by McNemar’s test. Kaplan–Meier analyses were 
performed to compare cumulative retention rates. All 
statistical analyses were carried out using IBM SPSS 
version 22.0 (SPSS, Chicago, IL, USA). In all analyses, 
p<0.05 was considered as statistical significance.
Results
Clinical evaluation scores of restorations are 
shown in Table 4. Most restored teeth were premolars 
(73%). After randomization, 53% were placed 
at the mandibular arch and 47% were placed at 
the maxillary arch. At baseline, all restorations 
scored alpha regarding the modified USPHS criteria 
evaluated (retention, marginal adaptation, marginal 
discoloration, surface texture, secondary caries, and 
postoperative sensitivity). 
Recall rates were 100% for 6-month and 93% for 
12-month assessments. At 6-month evaluations, one 
(1.5%) GP and two (3%) FB restorations lost retention 
(p>0.05). At 12-month recall, only one FB (1.7%) 
lost retention. The rates of cumulative retention loss 
after 12 months were 4.9% for FB and 1.6% for GP 
(p>0.05).
At 6-month assessments, nine FB (13.8%) and 
three GP (4.5%) restorations presented bravo scores 
for marginal adaptation (p>0.05). At 12-month 
examinations, FB (30.5%) restorations exhibited 
higher bravo scores than GP (6.5%) restorations for 
marginal adaptation (p<0.001). 
Regarding marginal discoloration, four FB (6.2%) 
and two GP restorations (3%) showed bravo scores 
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(p>0.05) at 6-month evaluations. After 12 months, 
FB restorations (20.3%) demonstrated higher bravo 
scores than GP restorations (6.5%), and the difference 
was statistically significant (p=0.024). 
At 6-month examinations, only two FB restorations 
showed bravo scores for surface texture. At 12-month 
assessments, a total of 10 (7 FB, 3 GP) restorations 
were scored as bravo, and the difference between the 
two groups was not statistically significant (p>0.05).
All restorations were scored as alpha regarding 
secondary caries and postoperative sensitivity after 
12 months. 
McNemar’s test presented significant changes in 
marginal adaptation and marginal discoloration after 
6 and 12 months for FB restorations (p<0.05). GP 
restorations presented significant changes in marginal 
adaptation and marginal discoloration after 12 months 
(p<0.05), compared to baseline. 
Discussion
This clinical trial was the first study to compare this 
new conventional GIC and a resin composite combined 
with a universal adhesive in NCCLs of patients with 
systemic diseases. The null hypothesis was partially 
accepted. Although the resin composite presented 
better results to restorative conventional GIC for 
marginal adaptation and marginal discoloration, no 
significant differences in retention between the two 
restorative materials were found. 
According to the manufacturer of the new 
conventional GIC, Fuji Bulk was suitable for patients 
with systemic diseases for its high resistance to acidic 
oral environment and high fluoride release capacity. 
Considering the biocompatibility and chemical 
adhesion benefits of GICs, these declarations were the 
Evaluation
Criteria Score
Baseline n (%) 6-month n (%) 12-month n (%)
FB (67) GP (67) FB (67) GP (67) FB (60) GP (62)
Retention
Alfa
67 67 65 66 59 62







67 67 56 63 41 58
(100) (100) (86.2) (95.5) (69.5) (93.5)
Bravo
9s 3 18s 4s




67 67 61 64 47 58
(100) (100) (93.8) (97) (79.7) (93.5)
Bravo
4s 2 12s 4s




67 67 63 66 52 59







67 67 65 66 59 62




67 67 65 66 59 62
(100) (100) (100) (100) (100) (100)
Charlie
sIndicates significant difference in comparison with baseline according to Cochran’s Q test fallowed by McNemar's test (p<0.05) FB: Fuji 
Bulk, GP: G-ænial Posterior. The outcomes were scored as alpha: clinically very good, bravo: clinically good, acceptable, charlie: clinically 
unacceptable.
Table 4- Clinical evaluation outcomes of restorations
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main reason to evaluate this product in patients with 
systemic disease who have a strong requirement for 
bioactive, biocompatible, maintenance friendly, and 
long-lasting restorations.
A wide range of restorative materials are available, 
and clinicians have the opportunity to choose the 
most suitable treatment for each individual patient. 
As resin-based materials and amalgam present minor 
biological side effects,26,27 GICs have become popular 
for the restoration of different type of cavities.28 Their 
advantages over resin composite restorative materials 
include fluoride release, chemical adhesion to tooth 
tissues, and similar physical properties to dentin. 
Moreover, fluoride release results in an anticariogenic 
environment that promotes remineralization.28 
However, undesirable esthetic properties of GICs are 
still a problem, hindering their use in patients with 
high esthetic demands. In this study, all restorations 
were placed in posterior teeth, as the new conventional 
GIC did not have an acceptable esthetic appearance.
Ozgunaltay and Onen29 (2002) reported that GIC 
showed a lower incidence of alpha scores for color 
match and marginal discoloration than the resin 
composite. In another clinical trial, resin composite 
restorations presented better marginal adaptation 
than GIC.30 In our study, the conventional GIC 
clearly demonstrated higher bravo rates for marginal 
adaptation than the tested resin composite. Marginal 
adaptation failures are mostly due to thermal and 
mechanical stresses in the oral cavity. Furthermore, 
water sorption, hydrolysis, and viscoelastic properties 
of the restorative material affect the marginal 
adaptation of NCCLs.31 In this study, bravo rates of 
marginal discoloration were consistent with marginal 
adaptation rates, and the similar ratings indicated the 
significance of fine marginal adaptation, leading to 
marginal discoloration.31 Sidhu32 (2010) investigated 
clinical outcomes of GICs and reported that they 
show better retention and lower secondary caries and 
postoperative sensitivity rates than resin composite 
restorations. However, marginal adaptation and 
discoloration, surface properties, and color stability 
of GICs did not present good results as other criteria 
in long-term clinical investigations. 
Several systemic diseases affect saliva flow and 
periodontal status of patients. Particularly, chronic 
diseases such as hypertension33 and diabetes 
mellitus34 may promote tissues (salivary glands) 
dysfunction. Drug-induced hyposalivation can be 
a problem for many types of medications, such as 
antihypertensive, antidiabetic and psychotherapeutic 
drugs, and antihistamines.35 After radiotherapy36 or 
chemotherapy,37 xerostomia may occur as a side effect. 
Such issues may have an adverse effect on patients’ 
quality of life and longevity of restorations. In addition 
to poor quality of life, hyposalivation leads to lower 
salivary pH, reduced buffering capacity, decreased 
oral clearance, and reduced immune defense function. 
Therefore, the type of restoration chosen is crucial for 
patients with systemic diseases or in remission after 
cancer treatment. In this study, NCCLs of 16 patients 
with hypertension, four with cardiac diseases, six with 
cancer in remission, five with diabetes mellitus, two 
with rheumatoid arthritis, two with chronic obstructive 
pulmonary disease, and one with lupus erythematosus 
were treated. Some patients had more than one of 
the diseases mentioned. The medications for these 
diseases may cause dehydration, affecting periodontal 
response, and resulting in poor oral health. On the 
other hand, these systemic diseases may also lead 
to non-plaque-induced gingival inflammation due to 
altered immune response.38 In this study, the gingival 
status of patients revealed slight inflammatory 
symptoms, even one week after prophylaxis, which 
could be related not only to their insufficient oral 
hygiene but also to oral sequences of their systemic 
diseases. This study revealed substantive outcomes for 
the challenging host conditions which have not been 
examined previously for the restoration of NCCLs, and 
this must be considered while interpreting the results. 
The adhesion capability of restorative systems is 
related to dentin hydration, sclerotic dentin formation, 
and elastic modulus of the restoration materials.39 
The dehydration of teeth due to xerostomia may 
have an adverse effect on the adhesion and integrity 
of restorative materials. A systematic review18 stated 
that restoring NCCLs using GIC resulted in better 
retention outcomes compared to a two- or three-step 
etch and rinse adhesive system. The studies reported 
that the elasticity of GICs similar to dentin and their 
better adhesion to calcified tooth tissues compared 
to adhesive systems may be the main reasons for 
the superior results of GICs.18 On the other hand, 
the more rigid characteristics of resin composite 
materials and the hybridization of dentin and 
micromechanical resin tags in enamel are advantages 
of resin-based materials and adhesive systems.40 
Phosphoric acid etching and adhesive systems may 
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lead to marginal adaptation of the restorative resin 
composite.30 Another clinical trial demonstrated that 
GIC restorations present higher bravo scores and 
higher rates of retention loss than resin composite 
restorations in NCCLs,30 similar to our study after 
24 months. However, the examiners concluded that 
patients with heavy bruxism may explain the higher 
rate of GICs loss. Conversely, Vaid, Shah and Bilgi41 
(2015) reported no significant difference between GIC 
and resin composite restorations regarding clinical 
performance after 12 months. 
The literature presents few reports of restorative 
treatment in patients with systemic diseases.42-44 
In patients with high caries risk, the placement of 
a viscous GIC is able to prevent the occurrence of 
secondary caries.42 McComb, et al.43 (2002) conducted 
a clinical trial in Class V cavities of patients who 
received radiotherapy and the results showed that 
retention loss occurred in only one resin-modified GIC 
restoration and eight resin composite restorations. 
None of the conventional GIC restorations failed. 
The resin composite group exhibited a significantly 
higher rate of retention loss after 24 months. A clinical 
investigation comparing GIC and amalgam restorations 
in xerostomic cancer patients reported that patients 
who did not use topical fluoride as directed, amalgam 
restorations showed significantly higher retention 
loss than GICs.44 Although previous studies have also 
presented positive findings regarding GIC restorations, 
it is impossible to directly compare these findings with 
those of our study, considering the diversity of test 
conditions, cavity types, and restorative materials. 
Our patients received oral hygiene training, 
but 3 of 28 patients developed new caries in their 
other teeth at 12-month evaluations. Their systemic 
conditions and the medications were thought to be 
the reasons for this in addition to their low ability to 
conduct personal oral hygiene as desired. The use 
of GIC restorations may contribute to oral health of 
patients with systemic diseases and cancer patients 
in remission after chemotherapy and radiotherapy 
treatment because of their ability to release fluoride 
and their improved retention rates.18 Furthermore, the 
time required to place a restoration in these patients 
is another important factor. The major advantage of 
GIC used in this study was the short-working time and 
lack of requirement for etching and adhesive protocols. 
Restorative treatments must be finished within a short 
time, when dealing with patients with serious health 
problems and medications. 
Some limitations of this study must be considered 
when interpreting the results. Firstly, our findings 
cannot be generalized to healthy patients of varying 
ages, as we focused on patients with chronic systemic 
diseases within a limited age range (50–69 years). 
Another limitation was the difference in systemic 
diseases of the participants. Although all of the 
included systemic diseases share the characteristic 
of reducing the saliva flow rate,45-49 their diverse 
mechanisms and/or medications may have affected 
the results. Moreover, the assessments of participants’ 
individual caries risk, particularly their dietary habits, 
which could also influence the study outcomes, were 
not examined. The short evaluation period represents 
another potential limitation of this study. However, 
limited clinical data on this new conventional GIC 
are available, and there have been no clinical results 
published to date. Therefore, further long-term studies 
addressing specific systemic diseases are required 
associated with discussions on the differences or 
similarities of the results. 
Although this study yielded promising results for 
this new conventional GIC for the restoration of NCCLs 
in patients with systemic diseases at 12 months, 
further evaluation of its long-term performance is 
required.
Conclusions
The resin composite presented superior results 
to the conventional restorative GIC for marginal 
adaptation and marginal discoloration. Both materials 
successfully restored NCCLs in patients with systemic 
disease during the 12-month evaluation period. 
Significant changes were observed in marginal 
adaptation and discoloration for both restorative 
materials tested over 12 months. 
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